Fed's in a Tough Spot<br />By Rev Shark<br />RealMoney.com Contributor<br />6/25/2008 8:53 AM EDT <br /><br /><br />When future historians look back on our way of curing inflation, they'll probably compare it to bloodletting in the Middle Ages. <br />-- Lee Iacocca<br /><br />The very poor action in the market recently is due in large part to increased concerns over inflation. The market could deal with a slowing economy, because the Fed can deal with that quite easily by simply cutting interest rates. Inflation, though, is a much more difficult problem, because raising rates obviously slows the economy, and that is tough medicine when things are as gloomy as they are now. <br /><br />It is inflation that is the issue out there, and the Fed interest rate decision today is going to give us some insight into what approach Ben Bernanke and his crew is likely to take. The market isn't expecting any interest rate moves today, but it isn't at all sure what to expect in the policy statement. <br /><br />We already have comments this morning from the European Central Bank making it clear that it is concerned about inflation and likely to raise rates in May. In addition, Brazil has raised its inflation forecast to 6% from 4.6% and is looking for it to peak at 6.3% in the third quarter. <br /><br />This rapidly increasing concern over inflation comes against a backdrop of rapidly diminishing investor sentiment. Consumer sentiment is hitting record low levels; investor sentiment this morning show far more bears than bulls, and the newspaper headlines about the real estate market are downright depressing. <br /><br />So we have inflationary concerns, poor economic and market sentiment and very ugly technical patterns in all the major indices as we await the Fed's comments today. So what is an investor to do at this point? <br /><br />It would be naïve to expect that the Fed is going to turn the tide of the market at this point. It might be able to produce some sort of bounce if it says the right things in the face of the intense gloominess out there, but anyone looking for a quick and easy recovery by this market is likely to be disappointed. <br /><br />The Fed is in a pretty ugly bind, and most astute market players realize that. It can't raise rates at this point without doing political damage and causing issues for our fragile economy, but it certainly can't afford to be dovish about inflation, which will kill the dollar even further and bolster oil and commodity inflation, which are already major problems. <br /><br />The likelihood is that that Fed is going to talk tough about inflation, ensure us of its vigilance, and do nothing. That might be enough to give us a little boost given that things are becoming quite negative, but a relief bounce at this point is more likely a selling opportunity than the beginning of a sustainable bottom. <br /><br />We have a slightly positive open on the way as oil prices pull back a tad and ECB President Jean-Claude Trichet talks tough about inflation. The longer-term technical picture looks horrible, but traders will be looking to the Fed to stir things up and give us some short-term opportunities. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: JBL +8.1% (also upgraded to Buy at Merrill), COMS +5.9%, AVAV +5.9% PRXL +5.5% (light volume), SLAB +4.6% (also announces plans to acquire Integration Associates; expected to be slightly dilutive to 2008 earnings, accretive in 2009), WMB +4.0%, DF +2.8%... M&A news: IONA +8.6% (Progress Software to acquire IONA Technologies for $4.05/share in cash)... Select European financials showing strength: BCS +5.7% (Barclays to shore up finances with $8.86 bln share issue - WSJ), UBS +2.8% (hires Lazard for review - NY Post), CS +2.6%, HBC +1.2%... Other news: NYNY +17.4% (Empire Resorts and Concord Associates announce New York State Legislature approves development of $1 bln new Concord Resort Destination), CRXL +8.8% (DSM Biologics and CRXL announce that they have entered into an agreement with Avid Bioservices to join their Vendor Network), LUX +6.6% (rises on planned confirmation of forecasts - Bloomberg.com), VM +6.2% (Financial Times reports co is to acquire the US mobile phone operation controlled by SKM of South Korea), NOK +5.4% (will add public wireless LAN access to its handsets in Japan in a bid to keep pace with smaller Japanese rivals - Reuters), MDCO +5.3% (discloses the United States House of Representatives passed a bill that would provide PTO with discretion to consider patent extension applications), GTI +4.5% (Cramer makes positive comments on MadMoney), WX +4.4% (Covance and WuXi PharmaTech to form a joint venture to provide preclinical services in China), TNB +3.5% (sells minority interest in Leviton Manufacturing for $300 mln; expects after-tax gain of ~$1.70 in Q2), VE +2.2% (still checking), OII +2.2% (Cramer makes positive comments on MadMoney), GFI +1.8% (Gold Fields' operational results for Q408 will be better than expected), RDS.A +1.4% (still checking), RMBS +1.4% (asks for ban on U.S. sales of Hynix chips after victory - Bloomberg.com)... Analyst comments: NDAQ +3.9% (upgraded to Buy at Piper), BP +2.5% (upgraded to Overweight at Morgan Stanley), NPBC +2.0% (upgraded to Outperform at Boenning & Scattergood), RGC +1.9% (upgraded to Outperform at BMO), T +1.6% (upgraded to Outperform at Bernstein).<br /><br />Allapoole avanevad:<br /><br />In reaction to strong earnings/guidance: APOG -11.1%, ROK -8.0% (light volume), SONC -6.1% (downgraded to Equal Weight at boutique firm), GIS -2.2% (light volume), MON -1.3%... Small-cap oil & gas names modestly pulling back after recent momentum: PDO -11.0%, ROYL -3.0%, IVAN -2.1%, FPP -1.8%... Other news: STEM -7.3% (files for mixed securities offering of up to $100 mln), ABB -3.5% (still checking), MCO -3.0% (SEC wants investors to reduce reliance on ratings - Bloomberg.com), GR -2.9% (still checking), TGIC -2.8% (it approved transitioning the business of its primary insurance operating subsidiary, Triad Guaranty Insurance Corp), ESLR -2.7% (announces offering of $300 mln of senior convertible notes and expected entry into a stock lending agreement and capped call transaction), RTP -1.7% (still checking)... Analyst comments: BA -3.6% (downgraded to Sell at Goldman), RPM -2.7% (downgraded to Hold at KeyBanc).